Related Experiment Video
Updated: Jun 28, 2026
16:15
Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
Postkidney transplant malignancy in Egypt has a unique pattern: a three-decade experience.
Ahmed F Donia1, Amani Mostafa, Hoda Refaie
1Urology and Nephrology Center, Mansoura University, Egypt.
Transplantation
|October 24, 2008
Summary
Post-transplant malignancy, including Kaposi sarcoma, occurred in 3.97% of kidney transplant recipients. Age and prior blood transfusions were identified as key risk factors for developing these cancers.
Area of Science:
- Nephrology
- Oncology
- Transplant Surgery
Background:
- Post-transplant malignancy patterns differ across transplant centers.
- Understanding these variations is crucial for patient care.
Purpose of the Study:
- To analyze the incidence, types, and risk factors of post-transplant malignancy in a single kidney transplant center.
- To compare outcomes between malignancy-free and malignancy-developing recipients.
Main Methods:
- Retrospective analysis of 1866 kidney transplantations performed between 1976 and 2007.
- Evaluation of 74 patients who developed post-transplant malignancy, compared to 1792 malignancy-free patients.
- Statistical analysis to identify independent risk factors.
Main Results:
- Post-transplant malignancy occurred in 3.97% of recipients.
- Kaposi sarcoma was the most common malignancy (36.8%), with a mean transplant-to-malignancy period of 2.84 years.
- Skin cancers accounted for 9.2%, predominantly basal cell carcinoma.
Conclusions:
- Kaposi sarcoma is the most frequent post-transplant malignancy in this cohort, necessitating further investigation.
- Age and prior blood transfusion are significant independent risk factors for post-transplant malignancy.
- The prevalence and types of post-transplant cancers are influenced by diverse factors.
Related Concept Videos
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...